The FDA has approved a new version of the anti-HIV drug efavirenz (Sustiva). (FDA Bits).
* The FDA has approved a new version of the anti-HIV drug efavirenz (Sustiva). The new 600 mg tablet will replace the three 200-mg tablets that are usually required once a day. The new tablet reduces the number of pills needed, which is a small step toward making anti-HIV medication easier to
In addition, make sure to read these articles:
- HEALTH CARE REPORT: New Drug for HIV Patients
- SRI International Takes Lead in Anti-HIV Drug andVaccine Development for NIAID; Four New...
- Bad to worse? (Treatment News).
- BMS' New Virology Dept. Battles HIV
- Gilead Begins Multinational Phase III Trial of OnceDaily Oral Anti-HIV Drug, Tenofovir...
- Tips for making the most of your medical care.
- Sustiva warnings.
- Clinical trial information.
- Timeline: AIDS.
- Keeping it real: "help! I've fallen and I can't get up!" preparing for an emergency if...
- Gilead Launches Web Site for New Anti-HIV Drug Viread.
- Caution: combination of Viread, Videx, and either Sustiva or Viramune.
- Over 80% of Patients on ATC Achieve Undetectable HIV After 24 Weeks.
Nutley-based pharmaceutical company Roche and Trimeris, Inc., Durham, N.C., announce that FUZEON, a novel treatment for HIV-1, has been approved by the U.S. Food and ......
Business Editors/Health & Medical Writers MENLO PARK, Calif.--(BUSINESS WIRE)--Sept. 6, 2000 SRI International, a leading research institute based in Silicon Valley, announced today that it ......
Last issue's "Treatment News" (see HIV Treatment ALERTS! November 2001: www.centerforaids.org/rita/alerts/alerts1101.htm) described a possible side effect of NRTI drugs: muscle weakness as a sign of ......
When Bristol-Myers Squibb (BMS) recently acquired Dupont Pharmaceuticals for $7.8 billion, it took control of SUSTIVATM, the No. 1 antiHIV medicine in its class. This ......
FOSTER CITY, Calif.--(BW HealthWire)--Nov. 30, 1999-- Gilead Sciences, Inc. (Nasdaq:GILD) announced today that it has begun enrolling patients in a multinational Phase III clinical trial ......
Do doctor visits make you nervous? When you are sitting in the exam room with your health care provider, do you suddenly forget what you ......
New precautions have been added to the labeling for Sustiva regarding interactions with Vfend (voriconazole), a drug used to treat serious fungal infections. Sustiva reduces ......
FAT WASTING STUDY LOOKS AT SWITCHING DRUGS Some people with HIV experience what is commonly known as lipodystrophy, which includes such symptoms as fat loss ......
For a disease barely 20 years old, AIDS has a tangled and complex history, both politically and medically. Here are a few milestones in the ......
When making presentations on HIV treatment issues, I always end with the same line: "These are the things you should know if you get hit ......
Business Editors & Health/Medical Writers FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 25, 2002 Gilead Sciences, Inc. (Nasdaq:GILD) today announced the launch of Viread.com, a Web site that ......
The combination of Viread, Videx, and either Sustiva or Viramune may cause early virologic failure in patients taking HIV needs for the first time. This ......
MELBOURNE, Australia -- Melbourne-based biotechnology company Avexa Limited (ASX:AVX) announced today positive 24 week data from the phase 2b clinical trial of apricitabine (ATC)....
Email
Digg It
del.icio.us
Related Resources
Press Releases
Business Resources
Sponsored Links
Site Map | Contact Us | FAQs | About Us | Media Kit | Reprints | RSS Directory | Sign Up for Free Newsletters | Disclosure Policy
Copyright © 1999 - 2008 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.
© Copyright 2008 The Gale Group, Inc. All rights reserved.
© Copyright © 2002 The Center for AIDS: Hope & Remembrance Project
You may not repost, republish, reproduce, package and/or redistribute the content of this page,
in whole or in part, without the written permission of the copyright holder.
© Copyright © 2002 The Center for AIDS: Hope & Remembrance Project
You may not repost, republish, reproduce, package and/or redistribute the content of this page,
in whole or in part, without the written permission of the copyright holder.
Get In-Depth Company Information from Hoover's | Buy a D&B Credit Report | What is in Your Company's D&B Credit Report? | Article Archives
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
Information and opinions on AllBusiness.com solely represent the thoughts and opinions of the authors and are not endorsed by, or reflect the beliefs of,
AllBusiness.com, its parent company D&B, and its affiliates.
AllBusiness.com, its parent company D&B, and its affiliates.
